Frazier Lifesciences Acqu... (FLACU)

NASDAQ: FLACU · Real-Time Price · USD

9.50

0.23 (2.48%)

At close: Nov 22, 2022, 8:59 PM

Frazier Lifesciences Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Net Income	-3.64M	2.87M	2.75M	4.18M	3.12M	1.39M	2.69M	-126.81K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	4.64M	1.23M	253.03K	223.06K	-175K	-409.96K	-438.94K	-474.64K
Other Non-Cash Items	-2.11M	-4.21M	-3.22M	-4.54M	-4.12M	-2.02M	-3.01M	42.35K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	5.54M	1.21M	144.06K	227.9K	-233.34K	-448.66K	-380.76K	-415.54K
Operating Cash Flow	-215.05K	-129.06K	-329.6K	-138.38K	-1.23M	-1.08M	-702.46K	-500K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	-138M	-138M	-138M	-138M
Investing Cash Flow	n/a	n/a	n/a	n/a	-138M	-138M	-138M	-138M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-45K	-45K	-45K	n/a	139.87M	139.87M	139.87M	139.87M
Financial Cash Flow	-45K	-45K	-45K	n/a	139.87M	139.87M	139.87M	139.87M
Net Cash Flow	-260.05K	-174.06K	-374.6K	-138.38K	139.14M	139.29M	139.66M	139.87M
Free Cash Flow	-215.05K	-129.06K	-329.6K	-138.38K	-1.23M	-1.08M	-702.46K	-500K